Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Alnylam Pharmaceuticals (ALNY)

Alnylam Pharmaceuticals (ALNY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,137,580
  • Shares Outstanding, K 115,357
  • Annual Sales, $ 219,750 K
  • Annual Income, $ -886,120 K
  • 60-Month Beta 1.86
  • Price/Sales 80.18
  • Price/Cash Flow N/A
  • Price/Book 12.80

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -1.07
  • Number of Estimates 6
  • High Estimate 2.52
  • Low Estimate -1.92
  • Prior Year -2.02
  • Growth Rate Est. (year over year) +47.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
128.32 +23.15%
on 06/16/20
164.09 -3.70%
on 07/07/20
+29.64 (+23.09%)
since 06/15/20
3-Month
120.05 +31.63%
on 06/12/20
164.09 -3.70%
on 07/07/20
+36.52 (+30.06%)
since 04/15/20
52-Week
69.11 +128.65%
on 08/06/19
164.09 -3.70%
on 07/07/20
+85.23 (+117.09%)
since 07/15/19

Most Recent Stories

More News
After Yesterday's Decline of 1.22%, Alnylam Pharmace Offers Investors Better Value

Alnylam Pharmace (NASDAQ:ALNY) traded in a range yesterday that spanned from a low of $149.85 to a high of $155.78. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of...

ALNY : 158.02 (+0.50%)
Alnylam (ALNY) Upgraded to Buy: Here's Why

Alnylam (ALNY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

ALNY : 158.02 (+0.50%)
Alnylam Announces that the United Kingdom's MHRA Grants Early Access to Lumasiran

--- Lumasiran Indicated Within EAMS for the Treatment of Patients with PH1 --

ALNY : 158.02 (+0.50%)
Alnylam Pharmaceuticals and Taiba Group Partner to Commercialize RNAi Therapeutics in the Gulf States

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, and taiba Middle East, a leading rare disease company based in the United Arab Emirates and covering the Middle East...

ALNY : 158.02 (+0.50%)
NASDAQ, S&P End 5-Day Winning Streaks

NASDAQ, S&P End 5-Day Winning Streaks

MSFT : 208.04 (-0.15%)
GPC : 88.26 (+2.43%)
SNBR : 53.63 (+3.67%)
STZ : 182.63 (+1.93%)
BBBY : 8.88 (+5.84%)
SOI : 7.37 (+2.93%)
THO : 110.95 (+4.72%)
SQQQ : 6.38 (-0.62%)
UNFI : 19.16 (+1.27%)
IAC : 129.84 (+1.78%)
RHP : 33.39 (+11.23%)
LVS : 50.25 (+6.04%)
HTHT : 35.48 (+3.08%)
RDS.A : 33.98 (+1.40%)
AYX : 162.45 (-1.63%)
MPC : 37.57 (+3.78%)
NEO : 36.51 (+3.40%)
STNE : 40.71 (+6.04%)
TJX : 52.63 (+5.56%)
TWTR : 35.67 (+3.75%)
XYL : 74.98 (+2.25%)
BLUE : 65.91 (+4.90%)
CRSP : 93.32 (+2.65%)
SGMO : 11.22 (+5.55%)
NTLA : 22.61 (+1.48%)
ACAD : 55.13 (+2.62%)
ALNY : 158.02 (+0.50%)
EDIT : 32.62 (+3.16%)
Look for Shares of Alnylam Pharmace to Potentially Pullback after Yesterday's 5.75% Rise

Alnylam Pharmace (NASDAQ:ALNY) traded in a range yesterday that spanned from a low of $153.52 to a high of $162.36. Yesterday, the shares gained 5.7%, which took the trading range above the 3-day high...

ALNY : 158.02 (+0.50%)
Alnylam Reports New 12-Month Interim Data From the ENVISION Phase 3 Study of Givosiran in Acute Hepatic Porphyria

--a^' Safety Profile Consistent With That Observed in the 6-Month Double-Blind Period, With No New Safety Findings a^'

ALNY : 158.02 (+0.50%)
Watch for Alnylam Pharmace to Potentially Rebound After Falling 1.52% Yesterday

Alnylam Pharmace (NASDAQ:ALNY) traded in a range yesterday that spanned from a low of $148.44 to a high of $152.27. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of...

ALNY : 158.02 (+0.50%)
Alnylam Pharmace Rises 1.50% on Heavy Volume: Watch For Potential Pullback

Alnylam Pharmace (NASDAQ:ALNY) traded in a range yesterday that spanned from a low of $152.61 to a high of $156.30. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high...

ALNY : 158.02 (+0.50%)
New GERM ETF Launched to Tap the Growing Biotech Sector

GERM invests in the hottest emerging biotechnology trends.

MRNA : 80.22 (+6.90%)
ALNY : 158.02 (+0.50%)
BIO : 498.35 (+1.92%)
SBIO : 43.06 (+2.38%)
PBE : 61.24 (+2.35%)
ARKG : 57.58 (+3.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade ALNY with:

Business Summary

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company is applying its therapeutic expertise in RNAi to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies,...

See More

Key Turning Points

2nd Resistance Point 161.22
1st Resistance Point 159.62
Last Price 158.02
1st Support Level 156.08
2nd Support Level 154.13

See More

52-Week High 164.09
Last Price 158.02
Fibonacci 61.8% 127.81
Fibonacci 50% 116.60
Fibonacci 38.2% 105.39
52-Week Low 69.11

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar